Morgan E. Meissner | Authors


Clinical Findings Identify Associations Between Genomic Correlates and Outcomes in Metastatic CRPC

July 12, 2019

A study aimed at exploring genomic diversity and defining its associations with clinical outcomes in metastatic castration-resistant prostate cancer found that alterations in RB1 were a potent predictor of poor survival and that other common aberrations may serve as prognostic indicators of treatment response, according to recent work published in the Proceedings of the National Academy of Sciences.